Concerned and diasappointed!

by Kazeem Olalekan MRPharmS A news article on the BBC Today program ( came to my attention yesterday about Avandia. It left me concerned for my patients and disappointed in the regulatory framework and in particular at GSK’s response. The concern about Avandia is not new. In

Read more